Keywords: avila, names, imclone, daniel, lynch, chairman, usa-based

Avila names ImClone's Daniel Lynch as chairman

Article | 22 December 2008

USA-based Avila Therapeutics has named Daniel Lynch as its executive chairman. Mr Lynch was previously chief executive and chief financial ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in